We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -5.13% | 9.25 | 9.00 | 9.50 | 9.75 | 9.25 | 9.75 | 58,268 | 10:46:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0163 | -5.67 | 16.1M |
TIDMSBTX
RNS Number : 6698H
SkinBioTherapeutics PLC
09 June 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or SkinBioTherapeutics the underlying issuer of existing shares to which voting rights are attached: (ii) ------------------------------------------------------------- ----------------------- 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------------- An acquisition or disposal of voting rights YES ---------------------------------------------------------------- -------------------- An acquisition or disposal of qualifying financial NO instruments which may result in the acquisition of shares already issued to which voting rights are attached ---------------------------------------------------------------- -------------------- An acquisition or disposal of instruments with NO similar economic effect to qualifying financial instruments ---------------------------------------------------------------- -------------------- An event changing the breakdown of voting rights NO ---------------------------------------------------------------- -------------------- Other (please specify): ------------------------------------------------------- ------- -------------------- 3. Full name of person(s) SPREADEX LTD subject to the notification obligation: (iii) --------------------------------------------------------- --------------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) --------------------------------------------------------- --------------------------- 5. Date of the transaction 30/05/2017 and date on which the threshold is crossed or reached: (v) --------------------------------------------------------- --------------------------- 6. Date on which issuer 08/06/2017 notified: --------------------------------------------------------- --------------------------- 7. Threshold(s) that is/are <3% crossed or reached: (vi, vii) --------------------------------------------------------- --------------------------- 8. Notified details: ----------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ----------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE -------------- -------------------------------- --------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights -------------- --------------- --------------- -------------- -------------------------- ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) -------------- ----------- ----------- -------------- ------------ ------------ ------------ ----------- Ordinary 1 - 3,233,333 3,233,333 2,933,333 2,933,333 2.47% --------------- --------------- -------------- ------------ ------------ ------------ ----------- GB00BF33H870 -------------- ----------- ----------- ------------ ---------- ------------ -------- --------- B: Qualifying Financial Instruments ----------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion rights that rights (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ------------------ ------------- ------------------------------- ---------------------------- --------------------- CFD/SPREADBET 501,445 0.42% ------------------ ------------- ------------------------------- ---------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ----------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) ---------------- ------------- ------------- ---------------- ---------------------------- ----------------------- Nominal Delta ---------------- ------------- ------------- ---------------- ---------------------------- ------------ --------- Total (A+B+C) ----------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights -------------------------------------------------- ------------------------------------------------------------------- 3,434,778 2.89% -------------------------------------------------- ------------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ---------------------------------------------------------------------------- Proxy Voting: ---------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ------------- 13. Additional information: ------------------------------------------------------------- ------------- 14. Contact name: DAVID CORBEN ------------------------------------------------------------- ------------- 15. Contact telephone number: 01727 895135 ------------------------------------------------------------- -------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLFLMLTMBJMMFR
(END) Dow Jones Newswires
June 09, 2017 05:38 ET (09:38 GMT)
1 Year Skinbiotherapeutics Chart |
1 Month Skinbiotherapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions